Andrew A. Nierenberg

32.5k total citations · 5 hit papers
445 papers, 21.2k citations indexed

About

Andrew A. Nierenberg is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Andrew A. Nierenberg has authored 445 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 253 papers in Psychiatry and Mental health, 137 papers in Pharmacology and 103 papers in Clinical Psychology. Recurrent topics in Andrew A. Nierenberg's work include Bipolar Disorder and Treatment (197 papers), Treatment of Major Depression (136 papers) and Schizophrenia research and treatment (91 papers). Andrew A. Nierenberg is often cited by papers focused on Bipolar Disorder and Treatment (197 papers), Treatment of Major Depression (136 papers) and Schizophrenia research and treatment (91 papers). Andrew A. Nierenberg collaborates with scholars based in United States, Denmark and Australia. Andrew A. Nierenberg's co-authors include Maurizio Fava, Jonathan E. Alpert, Roy H. Perlis, Stephen R. Wisniewski, Michael J. Ostacher, Roy H. Perlis, Michael E. Thase, George I. Papakostas, Michael W. Otto and David Mischoulon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Andrew A. Nierenberg

432 papers receiving 20.3k citations

Hit Papers

Long-Term implications of early onset in bipolar disorder... 2004 2026 2011 2018 2004 2020 2007 2006 2023 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)
    2004 656 citations Roy H. Perlis, Stephen R. Wisniewski et al. profile →
  2. Bipolar disorders
    2020 580 citations Roger S. McIntyre, Michael Berk et al. The Lancet profile →
  3. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
    2007 567 citations Andrew A. Nierenberg, Stephen R. Wisniewski et al. profile →
  4. Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    2006 519 citations Roy H. Perlis, Stephen R. Wisniewski et al. profile →
  5. Diagnosis and Treatment of Bipolar Disorder
    2023 141 citations Andrew A. Nierenberg, Ole Köhler‐Forsberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew A. Nierenberg United States 77 11.3k 5.5k 4.7k 4.2k 2.8k 445 21.2k
Lars Vedel Kessing Denmark 78 11.5k 1.0× 4.1k 0.7× 2.3k 0.5× 3.6k 0.9× 3.1k 1.1× 566 21.1k
Gin S. Malhi Australia 79 14.6k 1.3× 6.2k 1.1× 3.4k 0.7× 3.5k 0.9× 4.5k 1.6× 579 27.6k
Willem A. Nolen Netherlands 82 14.1k 1.2× 5.7k 1.0× 3.5k 0.7× 3.1k 0.8× 3.0k 1.0× 336 21.5k
Andrea Cipriani United Kingdom 71 10.8k 1.0× 4.9k 0.9× 6.4k 1.4× 4.3k 1.0× 2.9k 1.0× 390 25.4k
Ross J. Baldessarini United States 93 17.8k 1.6× 6.4k 1.2× 4.2k 0.9× 1.8k 0.4× 2.0k 0.7× 618 30.1k
Raymond W. Lam Canada 67 6.6k 0.6× 2.9k 0.5× 5.2k 1.1× 3.7k 0.9× 2.5k 0.9× 476 18.8k
Lakshmi N. Yatham Canada 68 14.0k 1.2× 3.4k 0.6× 3.1k 0.7× 1.8k 0.4× 2.9k 1.0× 390 19.8k
Alessandro Serretti Italy 75 9.0k 0.8× 7.4k 1.4× 5.8k 1.2× 5.3k 1.3× 4.4k 1.5× 738 26.4k
William Coryell United States 76 11.0k 1.0× 7.8k 1.4× 4.4k 0.9× 4.7k 1.1× 2.3k 0.8× 345 21.1k
Flávio Kapczinski Brazil 87 14.6k 1.3× 4.6k 0.8× 3.0k 0.6× 2.3k 0.5× 8.4k 3.0× 592 28.5k

Countries citing papers authored by Andrew A. Nierenberg

Since Specialization
Citations

This map shows the geographic impact of Andrew A. Nierenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew A. Nierenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew A. Nierenberg more than expected).

Fields of papers citing papers by Andrew A. Nierenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew A. Nierenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew A. Nierenberg. The network helps show where Andrew A. Nierenberg may publish in the future.

Co-authorship network of co-authors of Andrew A. Nierenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew A. Nierenberg. A scholar is included among the top collaborators of Andrew A. Nierenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew A. Nierenberg. Andrew A. Nierenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köhler‐Forsberg, Ole, et al.. (2025). Estimating the 12-Hour Serum Lithium Level (eLi<sub>12</sub>). The Journal of Clinical Psychiatry. 86(1).
2.
Rhee, Taeho Greg, Sung Ryul Shim, Kevin J. Manning, et al.. (2024). Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychotherapy and Psychosomatics. 93(1). 8–23. 22 indexed citations
3.
Rhee, Taeho Greg, Sung Ryul Shim, Brent P. Forester, et al.. (2022). Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode. JAMA Psychiatry. 79(12). 1162–1162. 61 indexed citations
4.
McIntyre, Roger S., Michael Berk, Elisa Brietzke, et al.. (2020). Bipolar disorders. The Lancet. 396(10265). 1841–1856. 580 indexed citations breakdown →
5.
Petersen, Timothy, Nathan Hall, Gustavo Kinrys, et al.. (2020). An evaluation of suicidal risk in bipolar patients with comorbid posttraumatic stress disorder. Journal of Affective Disorders. 266. 49–56. 6 indexed citations
6.
Lamon‐Fava, Stefania, Jisun So, David Mischoulon, et al.. (2020). Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukotrienes and Essential Fatty Acids. 164. 102219–102219. 47 indexed citations
7.
Nierenberg, Andrew A., et al.. (2016). L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry. Journal of Affective Disorders. 207. 429–433. 20 indexed citations
8.
Chang, Weilynn C., et al.. (2016). Physical Exercise for Treatment of Mood Disorders: A Critical Review. Current Behavioral Neuroscience Reports. 3(4). 350–359. 105 indexed citations
9.
Mischoulon, David, et al.. (2014). A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression. The Journal of Clinical Psychiatry. 76(1). 54–61. 58 indexed citations
10.
Baek, Ji Hyun, Lori Eisner, & Andrew A. Nierenberg. (2013). Smoking and suicidality in subjects with major depressive disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Affective Disorders. 150(3). 1158–1166. 18 indexed citations
11.
Nierenberg, Andrew A., et al.. (2011). The Current Crisis of Confidence in Antidepressants. The Journal of Clinical Psychiatry. 72(1). 27–33. 5 indexed citations
12.
Posternak, Michael A., Lee Baer, Andrew A. Nierenberg, & Maurizio Fava. (2011). Response Rates to Fluoxetine in Subjects Who Initially Show No Improvement. The Journal of Clinical Psychiatry. 72(7). 949–954. 14 indexed citations
13.
Nierenberg, Andrew A.. (2010). Switch or augment? Lessons from STAR*D.. PubMed. 22(4 Suppl 3). S4–8. 2 indexed citations
14.
Trivedi, Madhukar H., A. John Rush, Stephen R. Wisniewski, et al.. (2006). Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 67(2). 185–195. 141 indexed citations
15.
Denninger, John W., George I. Papakostas, Yasmin Mahal, et al.. (2006). Somatic Symptoms in Outpatients With Major Depressive Disorder Treated With Fluoxetine. Psychosomatics. 47(4). 348–352. 25 indexed citations
16.
Iosifescu, Dan V., Perry F. Renshaw, In Kyoon Lyoo, et al.. (2006). Brain white-matter hyperintensities and treatment outcome in major depressive disorder. The British Journal of Psychiatry. 188(2). 180–185. 47 indexed citations
17.
Papakostas, George I., Dan V. Iosifescu, Perry F. Renshaw, et al.. (2005). Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II). Psychiatry Research Neuroimaging. 140(3). 301–307. 42 indexed citations
18.
Papakostas, George I., Timothy Petersen, Gustavo Kinrys, et al.. (2005). Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder. The Journal of Clinical Psychiatry. 66(10). 1326–1330. 99 indexed citations
19.
Papakostas, George I., Timothy Petersen, John W. Denninger, et al.. (2004). Psychosocial Functioning During the Treatment of Major Depressive Disorder With Fluoxetine. Journal of Clinical Psychopharmacology. 24(5). 507–511. 55 indexed citations
20.
Mischoulon, David, et al.. (2001). Management of Major Depression in the Primary Care Setting. Psychotherapy and Psychosomatics. 70(2). 103–107. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Vedel Kessing Breakdown of academic impact, for papers by Gin S. Malhi Breakdown of academic impact, for papers by Willem A. Nolen Breakdown of academic impact, for papers by Andrea Cipriani Breakdown of academic impact, for papers by Ross J. Baldessarini Breakdown of academic impact, for papers by Raymond W. Lam Breakdown of academic impact, for papers by Lakshmi N. Yatham Breakdown of academic impact, for papers by Alessandro Serretti Breakdown of academic impact, for papers by William Coryell Breakdown of academic impact, for papers by Flávio Kapczinski
Rankless by CCL
2026